We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App





Eco-Friendly Immunoassay Reagents Featured at AACC 2015

By LabMedica International staff writers
Posted on 29 Jul 2015
A pioneering eco-friendly product line of unique, high quality immunoassay reagents that contains no toxic biological or chemical hazards are being exhibited at the 2015 AACC Meeting & Clinical Lab Expo (July 26–30; Atlanta, GA, USA), in Booth 4017.

ECO-TEK, the only commercially available line of environmentally safe immunoassay reagents, will be featured at AACC by Kem-En-Tec Diagnostics A/S (Taastrup, Denmark) and its US distributor, Rainbow Scientific, Inc. More...
(Windsor, CT, USA). Kem-En-Tec Diagnostics, a pioneer of safe and environmentally friendly immunoassay reagents that maintain high standards in quality, sensitivity, and shelf-life, develops ECO-TEK products to eliminate biological and chemical hazards such as BSA, sodium azide, and harmful organic solvents still commonly found in diagnostic assay components.

ECO-TEK reagents reduce the environmental impact of ELISA, blotting, or IHC applications without compromising reliability or stability. Additionally, Kem-En-Tec’s innovative WellChampion Blocking & Protection Buffer eliminates 2 to 3 steps in ELISA plate production, significantly reducing water waste.

Kem-En-Tec Diagnostics technical experts Henrik Christiansen, president & CEO, and Henny Nielsen, Sales & Marketing manager, will be present at the booth, providing visitors a firsthand opportunity to learn about the benefits of ECO-TEK reagents, especially for ELISA kit development. Visitors will also have an opportunity to arrange for free product samples.

“The latest developments from our R&D team provide enhancements in the dynamic range of TMB substrates and phycoerythrin (PE) labeled conjugates,” said Mr. Christensen, “The AACC offers us a unique chance to communicate our ability to meet the requirements of the immunoassay market to our customers and partners.”

“ECO-TEK products reduce environmental pollution from laboratory reagents, including elimination of mercury-containing waste,” said Peter Mousseau, president of Rainbow Scientific, “Visitors to our AACC booth will have the opportunity to speak to technical experts from Kem-En-Tec to learn about eco-friendly solutions for their labs.”

Kem-En-Tec Diagnostic products are registered and listed with the FDA as Device Class 1: General Purpose Reagents.

Related Links:

Rainbow Scientific
Kem-En-Tec Diagnostics
American Association for Clinical Chemistry



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.